Spearhead Capital Advisors, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spearhead Capital Advisors, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$222,000
+13.3%
34,459
+2.4%
0.03%
+3.8%
Q3 2021$196,000
-44.2%
33,658
-1.1%
0.03%
-45.8%
Q2 2021$351,000
+23.6%
34,029
+25.9%
0.05%
+14.3%
Q1 2021$284,00027,0230.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders